| Market Cap | ₹29Cr |
| ROE | 2.67% |
| P/E Ratio(TTM) | 9.38 |
| EPS(TTM) | 1.76 |
| P/B Ratio | 0.93 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.31 |
| Book Value | 17.66 |
| Debt to Equity | 1.76 |
| Face Value | 10 |
| Parent Organisation | Mono Pharmacare |
| Managing Director | Panilam Lakhatariya |
| Founded | 2022 |
| NSE Symbol | MONOPHARMA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.27 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.05 | ||
| Wockhardt | NA (0.00%) | -449.22 | ||
| Cohance Lifesciences | NA (0.00%) | 65.70 |